Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/06/20
End: 11/15/23
Due: 11/15/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection | NCT04247542 | Acurx Pharmaceuticals Inc. | user2@example.com | None | 2020-03-06 | 2023-11-15 | 2024-11-15 | - | - | 2025-07-14 |